NASDAQ: ACONAclarion Inc Stock Ownership - Who owns Aclarion?
Insider buying vs selling
Have Aclarion Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Amanda M. Williams | Director | 2026-08-17 | 5,857 | $2.73 | $15.99kBuy |
| Gregory A. Gould | CFO | 2026-08-14 | 10,000 | $2.45 | $24.50kBuy |
| Ryan Bond | Director | 2026-08-13 | 21,122 | $2.37 | $50.06kBuy |
| David K. Neal | Director | 2026-08-13 | 7,500 | $2.40 | $18.00kBuy |
| Brent Ness | CEO | 2026-08-13 | 5,234 | $2.31 | $12.09kBuy |
| William Wesemann | Director | 2026-08-13 | 2,150 | $2.34 | $5.03kBuy |
| Scott Breidbart | Director | 2026-05-12 | 5,664 | $3.18 | $18.01kBuy |
| Brent Ness | Chief Executive Officer | 2026-05-11 | 6,289 | $3.18 | $20.00kBuy |
| David K. Neal | Director | 2026-05-11 | 2,500 | $3.10 | $7.75kBuy |
| William Wesemann | Director | 2026-05-06 | 1,562 | $3.30 | $5.15kBuy |
ACON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACON insiders and whales buy or sell their stock.
ACON Shareholders
What type of owners hold Aclarion Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nuvasive Inc | 39.08% | 1,126,495 | $2.96M | Insider |
| Brent Ness | 3.87% | 111,534 | $293.33k | Insider |
| Jeffrey John Thramann | 3.47% | 100,000 | $263.00k | Insider |
| Ryan Bond | 2.64% | 76,122 | $200.20k | Insider |
| Gregory A. Gould | 2.08% | 60,000 | $157.80k | Insider |
| David K. Neal | 1.04% | 30,002 | $78.91k | Insider |
| Amanda M. Williams | 0.90% | 25,857 | $68.00k | Insider |
| Scott Breidbart | 0.89% | 25,664 | $67.50k | Insider |
| William Wesemann | 0.82% | 23,713 | $62.37k | Insider |
| John Paul Lorbiecki | 0.78% | 22,404 | $58.92k | Insider |
ACON vs Health Information Service Stocks
Aclarion Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.